Second Generation FIT® is the number one selling colon cancer screening test in North America for a reason. Now available in Africa, take the test when you want, in the privacy of your own home, with instant results. Here's what real customers say:
Second Generation FIT® is also the test of choice for large clinical trials. When the drug Casperome® was in clinical trials to manage patients with ulcerative colitis in remission, doctors depended on Second Generation FIT® to provide the vital information regarding remission status they needed using the fecal immunochemical test.